AR and brain neoplasm: Out of 19 PTEN-controlled TFs (AR is removed from our analysis to prevent bias toward prostate), we were able to derive 16, 15 and 16 TFAs from human prostate, breast and brain tumor datasets, respectively, based on the availability of their target gene expression values in the datasets.